Thorsten Kuhn
Overview
Explore the profile of Thorsten Kuhn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
1873
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Montagna G, Mrdutt M, Sun S, Hlavin C, Diego E, Wong S, et al.
JAMA Oncol
. 2024 Apr;
10(6):793-798.
PMID: 38662396
Importance: Data on oncological outcomes after omission of axillary lymph node dissection (ALND) in patients with breast cancer that downstages from node positive to negative with neoadjuvant chemotherapy are sparse....
12.
de Boniface J, Tvedskov T, Ryden L, Szulkin R, Reimer T, Kuhn T, et al.
N Engl J Med
. 2024 Apr;
390(13):1163-1175.
PMID: 38598571
Background: Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited statistical power, uncertain nodal radiotherapy target...
13.
Untch M, Kuhn T, Liedtke C, Luftner D, Thill M
Breast Care (Basel)
. 2024 Mar;
13(1):59-63.
PMID: 38425880
No abstract available.
14.
Krug D, Vladimirova V, Untch M, Kuhn T, Schneeweiss A, Denkert C, et al.
Breast
. 2024 Feb;
74:103701.
PMID: 38422624
Background: Neoadjuvant chemotherapy (NACT) is routinely used for patients with triple-negative breast cancer (TNBC). Upfront breast-conserving therapy (BCT) consisting of breast-conserving surgery (BCS) and adjuvant radiotherapy (RT) has been shown...
15.
Kontos M, Kanavidis P, Kuhn T, Masannat Y, Gulluoglu B
Breast Cancer Res Treat
. 2024 Jan;
204(2):389-396.
PMID: 38175449
Purpose: Targeted axillary dissection (TAD) for the axillary staging of clinically node-positive (cN +) breast cancer patients converting to clinically node negative post neoadjuvant chemotherapy (NAC), has gained popularity due...
16.
Banys-Paluchowski M, Hartmann S, Ditsch N, Krawczyk N, Kuhn T, de Boniface J, et al.
Breast Care (Basel)
. 2023 Dec;
18(6):428-439.
PMID: 38130814
Background: The past 3 decades have seen an unprecedented shift toward treatment de-escalation in surgical therapy of breast cancer. Summary: Radical mastectomy has been replaced by breast-conserving and oncoplastic approaches...
17.
Pelzer F, Troger W, Reif M, Schonberg S, Martin D, Muller C, et al.
Breast Cancer
. 2023 Nov;
31(1):124-134.
PMID: 37966690
Background: Few measurements of fatigue and quality of life have been performed during neoadjuvant chemotherapy of early breast cancer. This study evaluates fatigue and quality of life experienced by early...
18.
Thill M, Kolberg-Liedtke C, Albert U, Banys-Paluchowski M, Bauerfeind I, Blohmer J, et al.
Breast Care (Basel)
. 2023 Oct;
18(4):306-315.
PMID: 37900553
The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2023 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally...
19.
Park-Simon T, Muller V, Jackisch C, Albert U, Banys-Paluchowski M, Bauerfeind I, et al.
Breast Care (Basel)
. 2023 Oct;
18(4):289-305.
PMID: 37900552
Background: Each year the interdisciplinary Arbeitsgemeinschaft Gynäkologische Onkologie (AGO), German Gynecological Oncology Group Breast Committee on Diagnosis and Treatment of Breast Cancer provides updated state-of-the-art recommendations for early and metastatic...
20.
Marme F, Krieghoff-Henning E, Gerber B, Schmitt M, Zahm D, Bauerschlag D, et al.
Eur J Cancer
. 2023 Oct;
195:113390.
PMID: 37890350
Background: Sentinel lymph node (SLN) status is a clinically important prognostic biomarker in breast cancer and is used to guide therapy, especially for hormone receptor-positive, HER2-negative cases. However, invasive lymph...